| BRISTOL-MYERS SQUIBB PHARMA COMPANY Patent applications |
| Patent application number | Title | Published |
|---|
| 20100069373 | SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION - This invention relates to novel lactams of Formula (I): | 03-18-2010 |
| 20100056501 | SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION - This invention relates to novel lactams of Formula (I): | 03-04-2010 |
| 20100048541 | SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION - This invention relates to novel lactams of Formula (I): | 02-25-2010 |
| 20100009966 | SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION - This invention relates to novel lactams of Formula (I): | 01-14-2010 |
| 20090264419 | CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION - This invention relates to novel cyclic malonamides having the formula (I): | 10-22-2009 |
| 20090170866 | MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS - The invention described herein relates to methods and compositions useful in the diagnosis, treatment and management of cancers that express particular genes, including the moesin, caveolin 1, and/or yes-associated protein 1 genes. | 07-02-2009 |
| 20090170831 | SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION - Field of the Invention This invention relates to novel lactams of Formula (I): | 07-02-2009 |
| 20090111793 | HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTION - This invention relates to novel lactams having the formula (I): | 04-30-2009 |
| 20090069293 | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF AB PROTEIN PRODUCTION - This invention relates to novel lactams having the formula (I): | 03-12-2009 |
| 20090062256 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION - This invention relates to novel lactams having the Formula (I): | 03-05-2009 |
| 20080293692 | SUCCINOYLAMINO LACTAMS AS INHIBITORS OF A-BETA PROTEIN PRODUCTION - This invention relates to novel lactams having drug and bio-affecting properties, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome. | 11-27-2008 |
| 20080275024 | CYCLIC MALONAMIDES AS INHIBITORS OF ASS PROTEIN PRODUCTION - This invention relates to novel cyclic malonamides having the formula (I): | 11-06-2008 |
| 20080221087 | Substituted lactams as inhibitors of abeta protein production - This invention relates to novel lactams of Formula (I): | 09-11-2008 |
| 20080207602 | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION - This invention relates to novel lactams having the formula (I): | 08-28-2008 |
